Clinical Trial Update: AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects [Phase 2]

View source ↗

Summary

A completed Phase 2 multiple-dose study of AMG 714 in adults with moderate to severe psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AMG 714

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 2 | Status: COMPLETED